1.Successful Treatment of Hydroxychloroquine-Induced Recalcitrant Acute Generalized Exanthematous Pustulosis with Cyclosporine: Case Report and Literature Review.
Basak YALCIN ; Seray CAKMAK ; Betul YILDIRIM
Annals of Dermatology 2015;27(4):431-434
Acute generalized exanthematous pustulosis (AGEP) is a cutaneous reaction principally induced by drugs. Spontaneous resolution is observed in most patients. However, severe cases required systemic corticosteroid administration. Hydroxychloroquine, which is used to treat some dermatologic and rheumatologic diseases because of its anti-inflammatory and immunosuppressive effects, is an uncommon cause of AGEP. A 67-year-old female patient presented with severe AGEP due to hydroxychloroquine treatment. She was recalcitrant to supportive care and systemic corticosteroid treatment butwas successfully treated with cyclosporine. Hydroxychloroquine-induced AGEP occurs in women with underlying rheumatologic diseases, has a longer latent period, and has a severe course usually requiring systemic treatment.
Acute Generalized Exanthematous Pustulosis*
;
Aged
;
Cyclosporine*
;
Female
;
Humans
;
Hydroxychloroquine
2.Homocysteine and Fibrinogen Changes with L-thyroxine in Subclinical Hypothyroid Patients.
Basak CAKAL ; Erman CAKAL ; Berrin DEMIRBAS ; Mesut OZKAYA ; Selma KARAAHMETOGLU ; Rustu SERTER ; Yalcin ARAL
Journal of Korean Medical Science 2007;22(3):431-435
The aim of the present study was to evaluate plasma total homocysteine (Hcys) and serum fibrinogen concentrations in subclinical hypothyroid (SH) and overt hypothyroid patients before and after L-thyroxine (LT4) replacement and to compare them in euthyroid subjects. Fifteen SH and 20 hypothyroid premenopausal women were recruited in the study. We measured fasting plasma levels of Hcys and serum levels of free thyroxine (fT4), free triiodothyronine (fT3), thyrotropin (TSH), folate, vitamin B12, fibrinogen, renal functions, and lipid profiles in patients with SH and overt hypothyroid patients before and after LT4 treatment. Eleven healthy women were included in the study as a control group. Pretreatment Hcys levels were similar in SH and control subjects, whereas mean fibrinogen level of SH patients was higher than that of control subjects (p<0.05). Baseline Hcys (p<0.01) and fibrinogen (p<0.001) levels of the overt hypothyroid patients were significantly higher than those of the healthy subjects, and the pretreatment Hcys levels decreased with LT4 treatment (p<0.001). In conclusion, our data support that SH is not associated with hyperhomocysteinemia and Hcys does not appear to contribute to the increased risk for atherosclerotic disease in patients with SH.
Adult
;
Case-Control Studies
;
Female
;
Fibrinogen/biosynthesis
;
Folic Acid/blood
;
Homocysteine/*blood
;
Humans
;
Hypothyroidism/*blood/*diagnosis
;
Kidney/metabolism
;
Middle Aged
;
Thyrotropin/blood
;
Thyroxine/*blood
;
Triiodothyronine/blood
;
Vitamin B 12/blood
3.Internalized Stigma in Pediatric Psoriasis: A Comparative Multicenter Study
Erkan ALPSOY ; Mualla POLAT ; Ibrahim Halil YAVUZ ; Pelin KARTAL ; Didem Didar BALCI ; Ayse Serap KARADAG ; Asli BILGIC ; Ercan ARCA ; Bilge Fettahlioglu KARAMAN ; Selma EMRE ; Esra ADISEN ; Neslihan SENDUR ; Ozlem BILGIC ; Ayca Cordan YAZICI ; Basak YALCIN ; Rafet KOCA ; Kamer GUNDUZ ; Murat BORLU ; Tulin ERGUN ; Pinar DURSUN ; Serap Gunes BILGILI ; Asli Surer ADANIR ; Ayla GULEKON ; Gizem YAGCIOGLU ; Ertan YILMAZ ; Ufuk KAVUZLU ; Yesim SENOL
Annals of Dermatology 2020;32(3):181-188
Background:
Internalized stigma, adoption of negative attitudes and stereotypes of the society regarding persons’ illness, has not been studied previously in pediatric psoriasis patients.
Objective:
We aimed to investigate the internalized stigma in pediatric psoriasis patients and to determine differences according to factors affecting internalized stigma compared to adult psoriasis patients.
Methods:
This multicenter,cross-sectional, comparative study included 125 pediatric (55 female, 70 male; mean age±standard deviation [SD], 14.59±2.87 years) and 1,235 adult psoriasis patients (577 female, 658 male; mean age±SD, 43.3±13.7 years). Psoriasis Internalized Stigma Scale (PISS), Dermatology Life Quality Index (DLQI), Perceived Health Status (PHS), and the General Health Questionnaire (GHQ)-12 were the scales used in the study.
Results:
The mean PISS was 58.48±14.9 in pediatric group. When PISS subscales of groups were compared, the pediatric group had significantly higher stigma resistance (p=0.01) whereas adult group had higher scores of alienation (p=0.01) and stereotype endorsement (p=0.04). There was a strong correlation between mean values of PISS and DLQI (r=0.423, p=0.001). High internalized stigma scores had no relation to either the severity or localization of disease in pediatric group. However, poor PHS (p=0.007) and low-income levels (p=0.03) in both groups, and body mass index (r=0.181, p=0.04) in the pediatric group were related to high PISS scores.
Conclusion
Internalized stigma in pediatric patients is as high as adults and is related to poor quality of life, general health, and psychological illnesses. Unlike adults, internalized stigma was mainly determined by psoriasis per se, rather than disease severity or involvement of visible body parts, genitalia or folds.